A Brief Review on Hepatopulmonary Syndrome
DOI:
https://doi.org/10.61427/jcpr.v2.i2.2022.60Keywords:
Hepatopulmonary Syndrome, Liver Transplantation, Portal HypertensionAbstract
Hepatopulmonary Syndrome is defined as decreased saturation of arterial oxygen due to dilatation of pulmonary vasculature in the presence of portal hypertension or advanced liver disease. In the year 1977, hepatopulmonary syndrome was first proposed based on the clinical findings and autopsy. In the patients with chronic liver disease, pulmonary manifestations like pulmonary vascular dilatation were observed in the autopsies.In the liver disease setting, dyspnea is usually present in the patient. The onset of dyspnea is gradual and aggravates by exertion. Most of the patients are asymptomatic during the early stages. This review article mainly focuses on the epidemiology, pathophysiology, clinical manifestations, diagnosis along with the treatment and management. A multidisplinary approach is required with the involvement of hepatologists, pulmonologists, primary clinicians, addiction medicine specialist, transplant surgeons and clinical pharmacists in the management of HPS.
Downloads
References
Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest. 1977 Sep; 72(3):305-9.
Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, Müller C. Hepatopulmonary syndrome: prevalence andpredictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut. 2002 Dec; 51(6): 853-9.
Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl JMed. 2008 May 29; 358(22): 2378-87.
Soulaidopoulos S, Cholongitas E, Giannakoulas G, Vlachou M, Goulis I. Review article: Update on current andemergent data on hepatopulmonary syndrome. World J Gastroenterol. 2018 Mar 28; 24(12):1285-98.
Krowka MJ, Cortese DA. Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology. 1990 Jan; 11(1):138-42.
Mohammad Alizadeh AH, Fatemi SR, Mirzaee V, Khoshbaten M, Talebipour B, Sharifian A, Khoram Z, Haj-sheikh-oleslami F, Gholamreza-shirazi M, Zali MR. Clinical features of hepatopulmonary syndrome in cirrhoticpatients. World J Gastroenterol. 2006 Mar 28; 12(12):1954-6.
Anand AC, Mukherjee D, Rao KS, Seth AK. Hepatopulmonary syndrome: prevalence and clinical profile. IndianJ Gastroenterol. 2001 Jan-Feb; 20(1): 24-7.
Silvério Ade O, Guimarães DC, Elias LF, Milanez EO, Naves S. Are the spider angiomas skin markers ofhepatopulmonary syndrome? Arq Gastroenterol. 2013 Jul-Sep; 50(3):175-9.
Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. InternationalLiver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome andPortopulmonary Hypertension. Transplantation. 2016 Jul; 100(7): 1440-52.
Pascasio JM, Grilo I, López-Pardo FJ, Ortega-Ruiz F, Tirado JL, Sousa JM, Rodriguez-Puras MJ, Ferrer MT,Sayago M, Gómez-Bravo MA, Grilo A. Prevalence and severity of hepatopulmonary syndrome and its influenceon survival in cirrhotic patients evaluated for liver transplantation. Am J Transplant. 2014 Jun; 14(6): 1391-9.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Most read articles by the same author(s)
- Manasa Reddipalli, Monika Mattaparthi , Naga Vamsi Naik Bhukya, Oselebe Somto Dave, Himasree Pithani, Dasaratha Dhanaraju Magharla, A Study on the Drug Utilization Pattern of Oral and Inhaled Corticosteroids among the COPD Patients , Journal of Clinical and Pharmaceutical Research: JCPR Volume:1/Issue:4 (2021)
.